Kiadis Pharma Netherlands B.V.

Magenta Therapeutics is a biotechnology company focused on developing novel medicines for patients with autoimmune diseases, blood cancers, and genetic diseases.

Magenta Therapeutics

Pyxis Oncology is a biotechnology company specializing in the development of novel cancer therapies, particularly targeting the tumor microenvironment to enhance immune response.

Pyxis Oncology

AVEO Oncology is a biopharmaceutical company dedicated to advancing a broad portfolio of targeted medicines for oncology and other areas of unmet medical need.

AVEO Oncology

Nkarta is a biotechnology company focused on developing engineered natural killer (NK) cell therapies for cancer treatment.

Nkarta

Indapta Therapeutics is a biotechnology company specializing in the development of novel immunotherapies for the treatment of cancer.

Indapta

Orca Biosystems is a biotechnology company focused on developing innovative therapies for cancer, particularly in the field of immunotherapy.

Orca Biosystems

Alpex Pharma is a pharmaceutical company specializing in the development of therapies for various medical conditions, including oncology.

Alpex Pharma

Cornerstone Pharmaceuticals is a biopharmaceutical company focused on developing innovative cancer therapies that target metabolic pathways in cancer cells.

Cornerstone Pharmaceuticals

Viracta is a biotechnology company dedicated to developing precision medicines for the treatment of virus-associated cancers.

Viracta

Xhale is a biotechnology company specializing in the development of innovative therapies for respiratory diseases and oncology.

Xhale

ImpriMed is a biotechnology company focused on developing precision medicines for the treatment of blood cancers.

ImpriMed

TOLREMO therapeutics AG is a biopharmaceutical company dedicated to developing novel therapies for blood cancers and related disorders.

TOLREMO therapeutics AG

Kiadis Pharma is a biopharmaceutical company that specializes in the development of novel T-cell immunotherapy treatments for patients with blood cancers and inherited blood disorders. The company's lead product candidates are focused on making bone marrow transplantations safer and more effective. In 2021, Kiadis Pharma was acquired by Sanofi, which has integrated Kiadis's pipeline into its broader oncology portfolio.

Kiadis Pharma

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 14, 2024 5:26 AM	cfa522dd
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 18, 2024 2:12 PM	c8081dd2
crunchbase profile	general	Nov 18, 2024 2:46 PM	93ba8397
li profile	general	May 14, 2024 5:26 AM	984053a2
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

KIAD

COM:KIADIS

Kiadis Pharma